|
| Music On Prescription Could Help Treat Emotional And Physical Pain | Fri, 10 Sep 2010 |
| New research into how music conveys emotion could benefit the treatment of depression and the management of physical pain. Using an innovative combination of music psychology and leading-edge audio engineering the project is looking in more detail than ever before at how music conveys emotion... | |
| OpEds: Health Costs And New Law; Penn. Doctor Supply; Anesthesiologists Vs. Nurses | Wed, 08 Sep 2010 |
| Healthcare Reforms Don't Go Far Enough The Los Angeles TimesSome sort of Medicare-for-all program remains the only equitable way that every American can be provided with adequate and affordable coverage. This wouldn't be socialized medicine and it wouldn't be state-run healthcare (David Lazarus, 9/7). Despite Reform, Health Costs Are Still On The Rise The (Wilmington, Del... | |
|
| Treatment Of Pain To Feature At PAC10, Australia | Tue, 07 Sep 2010 |
| The management of persistent pain requires a different approach to that of acute pain. Whereas the initial problem can be addressed with acute pain, persistent pain requires restoration of physical, psychological and social function with minimisation of distress, decreasing the pain to a tolerable level rather than a cure and addressing the whole person in the rehabilitative process... | |
|
|
| Codeine-Ibuprofen Misuse Results In Serious Morbidity, Australia | Mon, 06 Sep 2010 |
| Although codeine-ibuprofen can be considered a relatively weak opioid analgesic, it is nevertheless addictive and more research is needed to develop health care responses to its misuse, according to an article in the Medical Journal of Australia... | |
| Molecules Involved In Touch And Other Mechanically Activated Systems Identified | Mon, 06 Sep 2010 |
| Scripps Research Institute scientists have identified two proteins with potential to be important targets for research into a wide range of health problems, including pain, deafness, and cardiac and kidney dysfunction. The study was published in Science Express, the advanced, online edition of the journal Science... | |
|
|
|
|
|
| The Face Of An Infant's Suffering; Can It Be Sugarcoated? | Thu, 02 Sep 2010 |
| When your newborn infant is crying with uncomfortable teething or otherwise obviously suffering, feeding sugar to the little one has been a home remedy for years based on not only perceived behavior, but also physiological reactions. However, a new article by Dr... | |
| QRxPharma Announces Interim Analysis Of Final Pivotal Phase 3 Study For MoxDuo®IR | Thu, 02 Sep 2010 |
| QRxPharma (ASX: QRX and OTCQX: QRXPY) announced a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140 patients has greater than 90% power to detect differences of analgesic effect, indicating there is no need to enrol additional patients... | |
| Floridians Prepare To Take Back The State | Thu, 02 Sep 2010 |
| September's National Pain Awareness Month has never been more important for the state of Florida. Recent data from the Florida Medical Examiner shows residents are dying at a rate of at least 7 per day as a result of prescription drug abuse... | |
|
| BEMA Buprenorphine Phase 2 Study Results Selected For Presentation At Pain Week 2010 | Wed, 01 Sep 2010 |
| BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced today that its abstract showing the results of a Phase 2 clinical study of BEMA Buprenorphine in the treatment of pain has been selected for oral presentation at Pain Week 2010, a national conference educating frontline clinicians who are faced with treating patients with pain... | |
|
| QRxPharma To Sponsor Symposium At 13th World Congress On Pain Meeting | Wed, 01 Sep 2010 |
| QRxPharma (ASX: QRX and OTCQX: QRXPY) announced it will sponsor a symposium at the 13th World Congress of Pain on 31 August, 2010 at Palais des congres de Montreal. The symposium, titled "Dual Opioid Therapy: Changing the Paradigm" will focus on preclinical and clinical data for MoxDuo®IR, an immediate-release Dual Opioid product for moderate to severe acute pain... | |
|
|
| "Pill Mill" Bill Requires State Certification By Sept. 1 | Wed, 01 Sep 2010 |
| Texans seeking pain relief soon can take comfort from a new state law requiring pain management clinics to be certified by the Texas Medical Board (TMB) by Sept. 1. Texas physicians hope the new law will put "pill mills," storefronts disguised as pain medicine clinics, out of commission... | |
|
| Hospira Japan Receives Approval For New Indication For 'Precedex IV(TM) 200ug' | Mon, 30 Aug 2010 |
| Hospira Japan Co., Ltd. announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV(TM)200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence... | |